Í»ÆÆèäèô | RMMR·¨¸ßЧºÏ³É¿Õ¼äλ×è¶àëÄ-ÔÆ¶¥¹ú¼Êvip.888" /> Åä¾°ÏÈÈݽüÄêÀ´£¬£¬£¬£¬£¬£¬¶àëÄÒ©ÎïÒòÔÚ¶àÖÖ¼²²¡ÁìÓòÕ¹ÏÖ³öÆæÒìÓÅÊÆ¶ø±¸ÊܹØ×¢£¬£¬£¬£¬£¬£¬µ«Æä½Ï²îµÄÎȹÌÐԺͽϵ͵Äϸ°ûÄ¤ÉøÍ¸ÐÔÑÏÖØÖÆÔ¼Á˶àëÄÒ©ÎïµÄ½øÒ»²½Éú³¤¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ÔÚ¶àëÄÁ´ÖÐÒýÈë¾ßÓпռäλ×èµÄ°±»ùËᣨÈçN-¼×»ù»¯°±»ùËá¡¢-ÔÆ¶¥¹ú¼Êvip.888" /> Í»ÆÆèäèô | RMMR·¨¸ßЧºÏ³É¿Õ¼äλ×è¶àëÄ-ÔÆ¶¥¹ú¼Êvip.888"> Åä¾°ÏÈÈݽüÄêÀ´£¬£¬£¬£¬£¬£¬¶àëÄÒ©ÎïÒòÔÚ¶àÖÖ¼²²¡ÁìÓòÕ¹ÏÖ³öÆæÒìÓÅÊÆ¶ø±¸ÊܹØ×¢£¬£¬£¬£¬£¬£¬µ«Æä½Ï²îµÄÎȹÌÐԺͽϵ͵Äϸ°ûÄ¤ÉøÍ¸ÐÔÑÏÖØÖÆÔ¼Á˶àëÄÒ©ÎïµÄ½øÒ»²½Éú³¤¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ÔÚ¶àëÄÁ´ÖÐÒýÈë¾ßÓпռäλ×èµÄ°±»ùËᣨÈçN-¼×»ù»¯°±»ùËá¡¢-ÔÆ¶¥¹ú¼Êvip.888"> ÔÆ¶¥¹ú¼Êvip.888">

ÐÂÎŶ¯Ì¬

Í»ÆÆèäèô | RMMR·¨¸ßЧºÏ³É¿Õ¼äλ×è¶àëÄ
·ÖÀà £ºÐÂÎÅ
Ðû²¼Ê±¼ä £º2025/10/26
»á¼ûÁ¿ £º


Åä¾°ÏÈÈÝ

½üÄêÀ´£¬£¬£¬£¬£¬£¬¶àëÄÒ©ÎïÒòÔÚ¶àÖÖ¼²²¡ÁìÓòÕ¹ÏÖ³öÆæÒìÓÅÊÆ¶ø±¸ÊܹØ×¢£¬£¬£¬£¬£¬£¬µ«Æä½Ï²îµÄÎȹÌÐԺͽϵ͵Äϸ°ûÄ¤ÉøÍ¸ÐÔÑÏÖØÖÆÔ¼Á˶àëÄÒ©ÎïµÄ½øÒ»²½Éú³¤¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ÔÚ¶àëÄÁ´ÖÐÒýÈë¾ßÓпռäλ×èµÄ°±»ùËᣨÈçN-¼×»ù»¯°±»ùËá¡¢¦Á,¦Á-¶þÈ¡´ú°±»ùËᣩ£¬£¬£¬£¬£¬£¬¿ÉÒÔÓÐÓÃÌá¸ßëĵÄÎȹÌÐÔºÍÄ¤ÉøÍ¸ÐÔ£¬£¬£¬£¬£¬£¬È»¶ø¹Å°åµÄ¹ÌÏàºÏ³É·¨Òò·Ç¾ùÏà·´Ó¦µÄÌØÕ÷£¬£¬£¬£¬£¬£¬ÔÚÒýÈëÕâЩ°±»ùËáʱ±£´æ·´Ó¦ËÙÂÊÂý£¬£¬£¬£¬£¬£¬Ð§ÂʵÍÒÔ¼°ËõºÏÊÔ¼ÁÏûºÄ´óµÈÎÊÌâ¡£¡£¡£¡£¡£¡£


»ùÓÚÉÏÊöÎÊÌâµÄ±£´æ£¬£¬£¬£¬£¬£¬ÄϾ©´óѧҦף¾üÍŶӿª·¢ÁËÒ»ÖÖ»ùÓÚÄâºËÌÇÌåµÄõ£»£»£»£»£» £»£»ù×ªÒÆ»úÖÆµÄÀο¿»¯·Ö×Ó·´Ó¦Æ÷RMMRs£¨Ribosome mimicking molecular reactors£©¡£¡£¡£¡£¡£¡£



RMMRÏÈÈÝ



RMMRÊ÷Ö¬ÊÇÒÔRinkõ£°·Ê÷֬Ϊ»ù´¡£¬£¬£¬£¬£¬£¬Í¨¹ýFmoc-LysÑÜÉúÎï¹¹½¨Ê÷֦״ÊèÉ¢µÄ»î»¯Î»µã£¬£¬£¬£¬£¬£¬×îÖÕÀο¿ÓÚAMÊ÷Ö¬ÉÏ£¨Í¼1£©£¬£¬£¬£¬£¬£¬ÆäÈÜÕÍÄÜÁ¦ÓëÉÌÓÃÊ÷Ö¬Ï൱£¬£¬£¬£¬£¬£¬ÇÒÎȹÌÐԺ㬣¬£¬£¬£¬£¬6¸öÔÂÄÚÎÞ½µ½â¡£¡£¡£¡£¡£¡£


ͼ1

ͼ 1 RMMRµÄ×é³É


¸Ã·´Ó¦Æ÷ÊÇͨ¹ýÔÚÊ÷Ö¬ÉÏÅþÁ¬ËĸöôÈ»ù»î»¯Î»µã£¨¼ûͼ2£©ºÍÒ»¸öëĺϳÉλµã£¬£¬£¬£¬£¬£¬ÔÚDICºÍN-Fmoc°±»ùËá±£´æÏÂÐγɶà¸ö»îÐÔõ¥ÖÐÐÄÌ壬£¬£¬£¬£¬£¬Ôö½øN¶Ë°±»ùºÍÏàÁÚ¼¤»îÖÐÐÄÌå¿ìËÙʵÏÖ·Ö×ÓÄÚ»ò·Ö×Ó¼äµÄO¡úNõ£»£»£»£»£» £»£»ù×ªÒÆ£¨½öÓÐÒ»¸öÑõõ£»£»£»£»£» £»£»ù¾ÙÐÐżÁª£©£¬£¬£¬£¬£¬£¬´Ó¶øÌá¸ß¿Õ¼äλ×èëĵĺÏЧ¹ûÂÊ£¬£¬£¬£¬£¬£¬×îºó¾­ßßऴ¦Öóͷ££¬£¬£¬£¬£¬£¬¿ÉͬʱÍê³ÉFmoc±£»£»£»£»£» £»£»¤»ùµÄÍѳýºÍδ·´Ó¦µÄ»îÐÔõ¥µÄÔÙÉú¡£¡£¡£¡£¡£¡£Æä×÷ÓûúÖÆÈçÏÂͼ3Ëùʾ¡£¡£¡£¡£¡£¡£

ÔÆ¶¥¹ú¼Ê¡¤(Öйú)Ψһ¹Ù·½ÍøÕ¾

ͼ2

ͼ2 ͨÓûîÐÔ¼¤»îÊÔ¼Á¼°ÆäÑÜÉúÎï

ÔÆ¶¥¹ú¼Ê¡¤(Öйú)Ψһ¹Ù·½ÍøÕ¾

ͼ3

ͼ3 RMMRs×÷ÓûúÖÆ



RMMRÓ¦ÓÃ




ͨÀý¶àëĺϳÉ


ÔÚͨÀý¶àëĵĺϳÉÖУ¬£¬£¬£¬£¬£¬»®·Ö½ÓÄÉÒÔOxyma-CºÍHOBt-CΪ»îÐÔλµãµÄRMMAÊ÷Ö¬ºÍÉÌÓÃRink AmideÊ÷Ö¬ºÏ³ÉËÄëÄQ-W-R-K-NH2ºÍ°ËëÄѪ¹ÜÖ÷ÒªËØIIõ£°·£¬£¬£¬£¬£¬£¬Ð§¹û¶ÔºÃ±Èϱí¡£¡£¡£¡£¡£¡£


±í1 ²î±ðÊ÷Ö¬ºÏ³ÉËÄëĺͰËëĵÄЧ¹û±ÈÕÕ

±í1ÔÆ¶¥¹ú¼Ê¡¤(Öйú)Ψһ¹Ù·½ÍøÕ¾

×¢£º±íÖÐÊýֵΪ´ÖÆ·´¿¶È


ʵÑéЧ¹ûÅú×¢£¬£¬£¬£¬£¬£¬RMMRÊ÷Ö¬ºÏ³ÉµÄ¶àëÄÔÚÖÊÁ¿ÉÏÓëÉÌÓÃRink AmideÊ÷Ö¬ºÏ³ÉµÄëÄÏ൱¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Ê¹ÓÃOxyma-C RMMRÊ÷Ö¬½ÓÄÉÊÖ¶¯ºÏ³ÉģʽµÄ´ÖÆ·´¿¶ÈΪ97%£¬£¬£¬£¬£¬£¬¶ø×Ô¶¯»¯ºÏ³ÉµÄ´¿¶ÈΪ94%£¬£¬£¬£¬£¬£¬Á½ÖÖ²Ù×÷ģʽЧ¹ûÏà½ü¡£¡£¡£¡£¡£¡£



¿Õ¼äλ×è¶àëĺϳÉ


  • N-¼×»ù»¯ëĵĺϳÉ

Ôںϳɺ¬ÓÐN-¼×»ù»¯°±»ùËáµÄ¶àëÄʱ£¬£¬£¬£¬£¬£¬RMMRÊ÷Ö¬ÏÔÖøÌá¸ßÁËËõºÏЧÂÊ£¬£¬£¬£¬£¬£¬²úÆ·´¿¶È×î¸ß¿ÉÖÁ98%£¬£¬£¬£¬£¬£¬¶øÊ¹ÓÃRink AmideÊ÷Ö¬ËùµÃ²úÆ·´¿¶È´ó¶¼µÍÓÚ20%¡£¡£¡£¡£¡£¡£²¿·ÖʵÀýÈçÏÂͼ4Ëùʾ¡£¡£¡£¡£¡£¡£


ͼ4

ͼ4 ²î±ðÊ÷Ö¬ºÏ³ÉN-¼×»ù»¯¶àëÄ


  • º¬¦Á,¦Á-¶þÈ¡´úµÄ¶àëĺϳÉ

RMMRÊ÷Ö¬Ôںϳɺ¬ÓЦÁ,¦Á-¶þÈ¡´ú°±»ùËá(ÈçAib£¬£¬£¬£¬£¬£¬¦Á-°±»ùÒì¶¡Ëá)µÄ¶àëÄʱͬÑùÌåÏÖ³öÓÅÒìµÄºÏ³ÉÄÜÁ¦¡£¡£¡£¡£¡£¡£¹ØÓÚº¬ÓÐÁ½¸öÒ»Á¬¦Á,¦Á-¶þÈ¡´ú°±»ùËáµÄÐòÁУ¨ÈçÏÂͼ5£©£¬£¬£¬£¬£¬£¬´¿¶È¿É´ï90%ÒÔÉÏ£¬£¬£¬£¬£¬£¬Ïà¶ÔµÄ£¬£¬£¬£¬£¬£¬ÉÌÓÃRink AmideÊ÷Ö¬ºÜÄÑÓÐÓúϳÉÏìÓ¦µÄ¶àëÄ¡£¡£¡£¡£¡£¡£


ͼ5ÔÆ¶¥¹ú¼Ê¡¤(Öйú)Ψһ¹Ù·½ÍøÕ¾

ͼ5 ²î±ðÊ÷Ö¬ºÏ³ÉÒ»Á¬¦Á,¦Á-¶þÈ¡´ú¶àëÄ


  • ÖØ´ó·Ö×Óalamethicin FÀàËÆÎïµÄºÏ³É


ͼ6

ͼ6 alamethicin FÀàËÆÎïµÄºÏ³É


¸ÃÍŶÓΪ½øÒ»²½ÑéÖ¤RMMRÊ÷Ö¬ÔÚÖØ´ó½á¹¹ÖеÄÊÊÓÃÐÔ£¬£¬£¬£¬£¬£¬½ÓÄÉOxyma-C RMMRÊ÷Ö¬ºÏ³ÉÁ˺¬ÓÐ8¸öAib²Ð»ùµÄalamethicin FÀàËÆÎ£¬£¬£¬£¬£¬ÊµÑéЧ¹ûÅú×¢£¬£¬£¬£¬£¬£¬RMMRÊ÷Ö¬¶ÔÖØ´ó¿Õ¼äλ×è¶àëÄͬÑù¸ßЧ£ºËùµÃ´ÖÆ·´¿¶È¿ÉÒԸߴï88%£¬£¬£¬£¬£¬£¬ÆäÊèÉ¢ÊÕÂÊÒ²µÖ´ïÁË73%¡£¡£¡£¡£¡£¡£


ÉÏÊöʵÑéÅú×¢£¬£¬£¬£¬£¬£¬RMMRϵÁÐÊ÷֬ͨ¹ýÆäÀο¿»¯õ£»£»£»£»£» £»£»ù×ªÒÆ»úÖÆ£¬£¬£¬£¬£¬£¬Í»ÆÆÁ˹Űå¹ÌÏàºÏ³ÉÔÚÖÆ±¸¿Õ¼äλ×èëÄʱµÄ¾ÖÏÞ£¬£¬£¬£¬£¬£¬ÏÔÖøÌá¸ßÁËËõºÏЧÂÊ¡£¡£¡£¡£¡£¡£



×ÜÌå½áÂÛ



RMMRϵÁÐÊ÷֬ͨ¹ýÄ£ÄâºËÌÇÌåµÄõ£»£»£»£»£» £»£»ù×ªÒÆ»úÖÆ£¬£¬£¬£¬£¬£¬ÎªºÏ³É¾ßÓÐÒ©ÓÃDZÁ¦µÄ¿Õ¼äλ×èëÄÌṩÁËÒ»ÖÖ¸ßЧÇÒ¿É¿¿µÄ½â¾ö¼Æ»®£¬£¬£¬£¬£¬£¬ÌØÊâÊÇÔÚÒýÈëN-¼×»ù»¯ºÍ¦Á,¦Á-¶þÈ¡´ú°±»ùËá·½ÃæÌåÏÖ¾«²Ê¡£¡£¡£¡£¡£¡£ÁíÍ⣬£¬£¬£¬£¬£¬Ó¦ÓôËϵÁÐÊ÷Ö¬ºÏ³ÉÌôÕ½ÐÔ°±»ùËᣬ£¬£¬£¬£¬£¬½öÐèʹÓÃÉÌÒµ»¯µÄFmoc°±»ùËáºÍDICÊÔ¼Á£¬£¬£¬£¬£¬£¬Í¬Ê±¼æÈÝÊÖ¶¯ºÍ×Ô¶¯ºÏ³Éģʽ£¬£¬£¬£¬£¬£¬Õ¹ÏÖ³öÁÉÀ«µÄÓ¦ÓÃÔ¶¾°¡£¡£¡£¡£¡£¡£



¹ØÓÚÔÆ¶¥¹ú¼Êvip.888



¾­ÓÉ22ÄêµÄ²»Ð¸Æð¾¢ºÍ»ýÀÛ£¬£¬£¬£¬£¬£¬Ôƶ¥¹ú¼Êvip.888ÉúÎïÔÚÈ«Çò¶àëĺϳÉÊÔ¼ÁÁìÓòÒ»Á¬Éî¸û£¬£¬£¬£¬£¬£¬ÏÖÒÑÉú³¤³ÉΪ¾ßÓÐÆÕ±é¶¨ÖÆ²úÆ·ÁýÕÖÄÜÁ¦ºÍÏÔÖø¹æÄ£»£»£»£»£» £»£»¯Éú²úÓÅÊÆµÄÁìÏÈÆóÒµ£¬£¬£¬£¬£¬£¬¿ÉÒÔÖª×ãÖÖÖÖ¿Í»§µÄÌØ¶¨ÐèÇ󡣡£¡£¡£¡£¡£ÎÒÃÇÕæÖ¿Ô¼Çë¶Ô¸Ã²úÆ·¸ÐÐËȤµÄ¿Í»§ÓëÎÒÃÇÁªÏµ£¬£¬£¬£¬£¬£¬ÒÔ±ã½øÒ»²½Ïàʶ²úÆ·ÏêÇ飬£¬£¬£¬£¬£¬²¢Ì½ÌÖºÏ×÷»ú»á¡£¡£¡£¡£¡£¡£



²Î¿¼ÎÄÏ×£º

[1] Wei, S.; Zhang, X.; Yao, Z., et al. Immobilized acyl-transfer molecular reactors enable the solid-phase synthesis of sterically hindered peptides[J]. Nat. Chem. 2025, 17, 1596?1606.




ÍøÕ¾µØÍ¼